Cannabis use by people with HIV is associated with an anti-inflammatory immunometabolic phenotype in monocyte-derived macrophages.

Overview

1. Department of Psychiatry, University of California,San Diego, 9500 Gilman Drive, La Jolla, CA 92093 USA
2. Department of Neurosciences, University of California,San Diego, La Jolla, CA USA
3. Department of Medicine, University of California San Diego,La Jolla, CA USA
4. San Diego Biomedical Research Institute,San Diego, CA USA

Abstract

Chronic neuroinflammation is associated with comorbidities in people with HIV (PWH) on antiretroviral therapy (ART). While cannabis use is associated with reduced neuroinflammation and neurocognitive impairment (NCI) in PWH, the underlying mechanisms are unknown. To address this gap in knowledge, we analyzed monocyte-derived macrophages (MDMs) from a cohort of 50 PWH and 33 people without HIV (mean age: 61.9 years), categorized by frequency of cannabis use (naïve/low, moderate, daily). We performed immunocytochemistry, RNA sequencing, and qPCR on MDMs and quantified related biomarkers in donor plasma. In this cohort study, daily cannabis use in PWH was associated with less global neurocognitive deficits, and with an anti-inflammatory immunometabolic-phenotype in MDMs characterized by (1) a metabolic shift from glycolysis to oxidative phosphorylation, (2) higher mitochondrial numbers, (3) altered cytokine profiles (pro-inflammatory downregulation, anti-inflammatory upregulation), and (4) higher brain-derived neurotrophic factor (BDNF) expression. These cellular changes were corroborated by a plasma biomarker profile in PWH including (1) lower levels of growth differentiation factor 15 and soluble triggering receptor expressed on myeloid cells 2, and (2) higher mature BDNF/precursor BDNF ratios that correlated with better cognition. Thus, cannabis use may mitigate NCI in PWH by immunometabolically reprogramming MDM function towards an anti-inflammatory and neuroprotective state.

Graphical Abstract: Cannabis use by people with HIV (PWH) is associated with neuroprotective and anti-inflammatory effects, mediated in part by reprogramming the immunometabolism of monocyte-derived macrophages (MDMs). This shift involves a transition from a pro-inflammatory, glycolytic phenotype toward a more anti-inflammatory state characterized by oxidative phosphorylation and altered cytokine expression.

In cannabis-Naïve/Low PWH, MDMs exhibit a pro-inflammatory profile that promotes neuroinflammation and mitochondrial damage, resulting in a reduced number of mitochondria. Chronic neuroinflammation contributes to neurodegeneration and the neurocognitive impairments (NCI) that define HIV-Associated Neurocognitive Disorders (HAND). This inflammatory and neurodegeneration profile is reflected by plasma immunometabolic biomarkers including reduced mature BDNF (mBDNF), and elevated GDF15 and soluble TREM2 (sTREM2) levels.

Conversely, cannabis use in PWH induces an anti-inflammatory MDM profile that promotes reduced neuroinflammation with increased mitochondrial biogenesis. The reduced neuroinflammation leads to improved neuronal function and reduced NCI, resulting in improved memory, motor and verbal skills, and executive learning. This neuroprotective effect is corroborated by corresponding plasma biomarkers showing increased mBDNF levels, and decreased GDF15 and sTREM2 levels. Collectively, these findings suggest that cannabis use by PWH appears to mitigate neuroinflammation and NCI, with the immunometabolic reprogramming of MDMs likely playing a key mechanistic role.

Graphical Methods

The HIV Neurobehavioral Research Program (HNRP) donor cohort consisted of people without HIV (PWoH) and people with HIV (PWH) who were either cannabis naïve/low, moderate cannabis users, or daily cannabis users. Peripheral blood mononuclear cells (PBMCs) were isolated from donor blood samples, plated, and allowed to differentiate for two weeks into monocyte-derived macrophages (MDMs) before being tested or treated with THC and then tested. At the same time plasma samples were isolated from each donor and stored for testing. At that point specific dyes were added, and different parameters were measured such as on the CX5 CellInsight Imager or an ELISA and the data was then analyzed.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

The paper's code and data availability statement is in the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

• geo:GSE285294, at NCBI GEO; found in “Data availability”

Data availability

The datasets supporting the conclusions of this article are included within the article, and the RNAseq data was published in the GEO database and is accessible under accession number GSE285294 and available at [GEO Accession viewer](https:/www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285294). The gene expression analysis code was submitted to the international open-access repository Dryad.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 29 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 18 authors, 5 keywords, 11 MeSH terms, 3 funders, 129 references.

Cite

This paper

Ford, M. K., Halcrow, P. W., Laird, A. E., Avalos, B. L., Boustani, A., Spencer, M., Melcher, J. I., Walter, K. C., Hong, D. D., Funk, G., Searson, E. G., Le, A. A., Ellis, R. J., Letendre, S., Marcondes, M. C. G., Schlachetzki, J. C., Iudicello, J., & Fields, J. A. (2026). Cannabis use by people with HIV is associated with an anti-inflammatory immunometabolic phenotype in monocyte-derived macrophages. Journal of neuroinflammation, 23(1), 173. https://doi.org/10.1186/s12974-026-03779-2

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1128/jvi.02063-25

HIV transgenic mouse monocytes display increased <i>in vivo</i> migration across the blood-brain barrier associated with increased expression of genes associated with mononuclear leukocyte movement.

Journal: Journal of virology

In common: other condition, cellular / molecular, 2 references

[2] doi:10.7554/elife.109888 [code]

Intravital calcium imaging of meningeal macrophages reveals niche-specific dynamics and aberrant responses to brain hyperexcitability.

Journal: eLife

In common: cellular / molecular, 2 references

[3] doi:10.1016/j.omtn.2026.103063 [code]

<i>In vivo</i> genome editing of central nervous system SIV reservoirs in ART-suppressed rhesus macaques.

Journal: Molecular therapy. Nucleic acids

In common: cellular / molecular, 2 references

[4] doi:10.3390/bioengineering13040413 [code]

HIV-Associated Microstructural Abnormalities in Default Mode, Executive Control, and Salience Networks: Insights from Tensor-Valued Diffusion Encoding.

Journal: Bioengineering (Basel, Switzerland)

In common: other condition, 2 references

[5] doi:10.3390/pathophysiology33030043

A Differentiated SH-SY5Y Model of Hypoxic-Ischaemic Injury Reveals Dynamic Transcriptomic Responses During Reoxygenation.

Journal: Pathophysiology : the official journal of the International Society for Pathophysiology

In common: other condition, cellular / molecular, 1 reference

[6] doi:10.1371/journal.ppat.1014351 [code]

Central Nervous System T-cell immune architecture, and not HIV burden, tracks with cognition under long-term viral suppression.

Journal: PLoS pathogens

In common: other condition, 1 reference

[7] doi:10.1038/s41467-026-74253-z

Disruption of the brain-spleen axis impairs monocyte-microglia communication and accelerates disease progression in a mouse model of amyloidosis.

Journal: Nature communications

In common: cellular / molecular, 1 reference

[8] doi:10.3389/fnins.2026.1775047 [code]

A multimodal imaging-based integrative framework for HIV-associated cognitive impairment and treatment response.

Journal: Frontiers in neuroscience

In common: other condition, 1 reference

[9] doi:10.1016/j.isci.2026.116541 [code]

The role of ucOCN in aerobic exercise induced amelioration of autism spectrum disorder phenotypes.

Journal: iScience

In common: cellular / molecular, 1 reference

[10] doi:10.3390/cancers18132092

TGFB2 as a Prognostic Biomarker Associated with Myeloid-Enriched, Multi-Checkpoint-Activated Immunosuppression in Diffuse Glioma: A Multi-Cohort Transcriptomic Study.

Journal: Cancers

In common: other condition, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.